How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures
双磷酸盐如何影响骨基质和重塑:对非典型股骨骨折的影响
基本信息
- 批准号:10586949
- 负责人:
- 金额:$ 46.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-12 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAlendronateAutomobile DrivingAwarenessBiologicalBone MatrixBone remodelingCell DensityCellsCompensationContralateralDataDepressed moodDevelopmentDietFatigueFemoral FracturesFormulationFractureFunctional disorderGrantHolidaysIbandronateImpairmentIndividualKineticsLaboratoriesLactationLifeLong-Term EffectsLow PrevalenceModelingMolecular StructureOperative Surgical ProceduresOsteoblastsOsteoclastsOsteogenesisOsteoporosisPathogenesisPatientsPharmaceutical PreparationsPhasePopulationPre-Clinical ModelPredispositionPreventionPrevention strategyProcessPropertyQualifyingRadiology SpecialtyRaloxifeneRattusReportingResearchRisedronateRiskRoleSecondary toSelective Estrogen Receptor ModulatorsSiteSkeletonSurfaceTestingTissuesWorkZoledronatebisphosphonatebonebone fatigueimprovedinnovationinterestmedication compliancenegative affectnovelosteoblast proliferationosteoprogenitor cellresponseside effectskeletaltreatment strategy
项目摘要
Project Summary / Abstract
Atypical femoral fractures (AFFs) are a rare but devastating side effect of long-term bisphosphonate (BP)
treatment. Despite the relatively low prevalence of AFFs, public awareness has considerably depressed
osteoporosis medication adherence. The mechanisms driving BP associated AFFs remain elusive and several
mechanisms have been proposed, including impaired bone remodeling, altered bone matrix maturation, and
the accumulation of tissue microdamage. A critical barrier to understanding how BPs negatively affect skeletal
integrity is the difficulty in separating the individual contributions of altered remodeling kinetics (suppressed
resorption and formation) from bone matrix maturation. We will overcome this barrier with our recently
validated rat model of induced cortical remodeling to investigate mechanism and treatment, based on robust
preliminary work in the laboratories of the three multiPIs. The current proposal, submitted in response to a
notice of special interest on AFF pathophysiology (NOT-AR-21-006), will test the central hypothesis that BPs
degrade skeletal integrity by affecting both the initiation of bone formation and matrix maturation. In Aims 1 and
2, we will focus on alendronate because of its strong association with the development of AFFs and raloxifene
as a potential mitigating treatment due to its reported positive effects on both the formation and matrix
maturation processes. Specifically, we will investigate the effects of alendronate and raloxifene on the initiation
of bone formation, concentrating on the role of reversal cells (Aim 1) and the remodeling independent effects of
these two drugs on matrix maturation and fatigue life (Aim 2). To determine if BP molecular structure could
play a role in AFF susceptibility, we will also compare how alendronate, zoledronate, risedronate, and
ibandronate affect bone formation, matrix maturation, and fatigue life (Aim 3). We will utilize an innovative
preclinical model and leverage the expertise of a highly qualified research team to address critical questions
associated with AFFs. If successful, the project will (i) further the understanding of the consequences of BP
usage on the skeleton by disentangling bone formation initiation and matrix maturation, identifying factors that
contribute to BP-induced loss of fatigue life and (ii) examine raloxifene as a novel rapid treatment option for
patients at risk for BP-induced AFF.
项目总结/摘要
非典型股骨骨折(AFFs)是一种罕见的,但破坏性的副作用,长期双膦酸盐(BP)
治疗尽管AFFS的发病率相对较低,但公众意识却相当低落,
骨质疏松症药物治疗依从性。驱动BP相关AFF的机制仍然难以捉摸,
已提出的机制包括骨重建受损、骨基质成熟改变和
组织微损伤的累积。了解BP如何对骨骼产生负面影响的关键障碍
完整性是分离改变的重塑动力学(抑制的)的个体贡献的困难
吸收和形成)。我们将克服这一障碍,
经验证的诱导皮质重塑大鼠模型,以研究机制和治疗,基于鲁棒性
在三个multiPI实验室的初步工作。目前的提案是根据一项
关于AFF病理生理学的特别关注通知(NOT-AR-21-006)将检验中心假设,即BP
通过影响骨形成和基质成熟的起始而降低骨骼的完整性。在目标1和
2、我们将重点关注阿仑膦酸钠,因为它与AFFs和雷洛昔芬的发展密切相关。
作为一种潜在的缓解处理,因为据报道其对地层和基质都有积极影响
成熟过程。具体来说,我们将研究阿仑膦酸钠和雷洛昔芬对启动的影响,
骨形成,集中在逆转细胞的作用(目的1)和重建的独立影响,
这两种药物对基质成熟和疲劳寿命的影响(目的2)。为了确定BP分子结构是否能
在AFF易感性中发挥作用,我们还将比较阿仑膦酸钠、唑来膦酸盐、利塞膦酸盐和
伊班膦酸盐影响骨形成、基质成熟和疲劳寿命(目的3)。我们将采用创新的
临床前模型,并利用高素质研究团队的专业知识来解决关键问题
与AFFS有关。如果成功,该项目将(i)进一步了解BP的后果
通过解开骨形成起始和基质成熟,鉴定
有助于BP引起的疲劳寿命的损失和(ii)检查雷洛昔芬作为一种新的快速治疗选择,
有BP诱发AFF风险的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Levin Geiser Andersen其他文献
Thomas Levin Geiser Andersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Levin Geiser Andersen', 18)}}的其他基金
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
常染色体显性骨硬化症 II 型骨脆性机制:从人到小鼠再到背部
- 批准号:
10366576 - 财政年份:2022
- 资助金额:
$ 46.49万 - 项目类别:
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
常染色体显性骨硬化症 II 型骨脆性机制:从人到小鼠再到背部
- 批准号:
10689658 - 财政年份:2022
- 资助金额:
$ 46.49万 - 项目类别:
Role of senescence in multiple myeloma tumorigenesis
衰老在多发性骨髓瘤肿瘤发生中的作用
- 批准号:
10571047 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
Role of senescence in multiple myeloma tumorigenesis
衰老在多发性骨髓瘤肿瘤发生中的作用
- 批准号:
10659259 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
Role of senescence in multiple myeloma tumorigenesis
衰老在多发性骨髓瘤肿瘤发生中的作用
- 批准号:
10352638 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 46.49万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 46.49万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 46.49万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 46.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists